Accuray (ARAY) Income from Discontinued Operations (2011 - 2012)
Accuray (ARAY) posted Income from Discontinued Operations of -$3.7 million for Q4 2012, up 74.43% on a QoQ basis from -$14.3 million in Q3 2012, and down 3417.31% year-over-year from $110270.1 in Q1 2012.
Powered by 
Analysis
Accuray (ARAY) Income from Discontinued Operations (2011 - 2012) Analysis & Trends
Accuray has reported Income from Discontinued Operations for 2 years, with the latest figure at -$3.7 million in Q4 2012.
- On a quarterly basis, Income from Discontinued Operations fell 3417.31% year-over-year to -$3.7 million in Q4 2012; TTM through Jun 2013 was -$18.0 million, a 2495.81% decrease from a year earlier, with the FY2013 full-year figure at -$5.9 million, down 746.53% from the prior year.
- Income from Discontinued Operations was -$3.7 million for Q4 2012 at Accuray, up from -$14.3 million in the prior quarter.
- The five-year high for Income from Discontinued Operations was -$96000.0 in Q1 2012, with the low at -$14.3 million in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | - |
| 10 | Accuray | 31.25 Mn | -11.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | -3.66 Mn |
| Sep 30, 2012 | -14.31 Mn |
| Jun 30, 2012 | -251,000.00 |
| Mar 31, 2012 | -96,000.00 |
| Dec 31, 2011 | -104,000.00 |
| Sep 30, 2011 | -241,000.00 |